Abstract
Recent retrospective studies suggest that beta-adrenergic blocking drugs (BB) are associated with improved outcomes in patients with a range of cancers. Although limited and discordant data suggest that BB may increase overall survival (OS) in localized breast cancer (BC), there is no information on the effects of BB in women with advanced BC. To explore the association between BB use and BC outcomes, we retrospectively reviewed ROSE/TRIO-012, a double-blinded, multinational phase III trial that randomized 1144 patients with HER2-negative advanced BC to first-line docetaxel in combination with ramucirumab or placebo. We compared progression-free survival (PFS), OS, overall response rate, and clinical benefit rate in patients who received BB to those who did not. 153/1144 (13%) patients received BB; 62% prior to enrolment and 38% began after enrolment. Median PFS in BB treated patients was longer than in patients who did not receive them (10.3 versus 8.3 months; HR 0.81; 95% CI 0.66-0.99; P = 0.038). Patients treated with BB only after enrolment had even higher median PFS (15.5 versus 8.3 months, P < 0.001). In the TNBC subset, median PFS was 13.0 months with BB, compared to 5.2 months without BB (HR 0.52; 95% CI 0.34-0.79; P = ...Continue Reading
References
Aug 9, 2003·Cancer Chemotherapy and Pharmacology·Masami NiiyaMitsune Tanimoto
Jan 30, 2007·Endocrine-related Cancer·E Tiligada
Sep 9, 2010·Cancer Research·Erica K SloanSteven W Cole
Apr 9, 2011·Annals of Surgery·Yael GoldfarbShamgar Ben-Eliyahu
Apr 30, 2011·Journal of the National Cancer Institute·Brian I RiniRobert J Motzer
Jun 3, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Amal Melhem-BertrandtAna-Maria Gonzalez-Angulo
Jun 3, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas I BarronKala Visvanathan
Mar 15, 2013·The Oncologist·Herbert I HurwitzOliver Rosen
Jun 20, 2013·Cancer Prevention Research·Paul A VoldenSuzanne D Conzen
Feb 19, 2014·International Journal of Epidemiology·Chris R CardwellDes G Powe
Apr 17, 2015·British Journal of Cancer·A ReederM S Flint
Jul 22, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John R MackeyRodrigo Fresco
Aug 25, 2015·Cancer·Jack L WatkinsAnil K Sood
Feb 27, 2016·International Journal of Cancer. Journal International Du Cancer·Sara RaimondiSara Gandini
Mar 5, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J R MackeyUNKNOWN Translational Research In Oncology (TRIO)/ Breast Cancer International Research Group (BCIRG)-005 investigators
Apr 17, 2016·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Lars Ivo ParteckeWolfram von Bernstorff
May 18, 2016·Cancer Treatment Reviews·Janick WeberpalsHermann Brenner
Citations
May 18, 2018·Epidemiology·Gonzalo SperaJohn R Mackey
May 18, 2018·Epidemiology·Gitte Vrelits SørensenThomas P Ahern
Mar 22, 2019·The Cancer Journal·Stefania OrecchioniFrancesco Bertolini
Sep 19, 2019·Oncogene·Shu-Heng JiangZhi-Gang Zhang
May 22, 2020·Bioscience Reports·Chaoran LiWeihong Zhang
Dec 6, 2017·Acta Oncologica·Deirdre Cronin-FentonHenrik T Sørensen
Nov 27, 2019·Cancers·Ondrej FialaJindrich Finek
Sep 26, 2020·Frontiers in Oncology·Shirui DaiZhaoyang Zeng
Aug 15, 2020·Cancer Reports·Alok Kumar Dwivedi, Rakesh Shukla
Apr 3, 2020·Cancer Biology & Therapy·Li DanniTeng Yuee
Sep 28, 2020·Cancer Chemotherapy and Pharmacology·Heitor Pinhata CecilioDaniel Galera Bernabé
Aug 8, 2020·Frontiers in Oncology·Natansh D ModiAshley M Hopkins
Oct 18, 2019·Cancer Prevention Research·Boris MravecPavel Babal
Dec 2, 2020·European Journal of Haematology·Yi L HwaAngela Dispenzieri
Feb 7, 2021·Bone Research·Francisco ConceiçãoMeriem Lamghari
Mar 3, 2021·Journal of Medicinal Chemistry·Minru LiaoBo Liu
Feb 28, 2021·ESMO Open·R CaparicaE de Azambuja
Jul 12, 2020·Journal of Neuroimmunology·Boris MravecLubica Horvathova
Jun 1, 2021·Frontiers in Pharmacology·Yuxiu XieZhijun Dai
Jul 3, 2021·International Journal of Molecular Sciences·Boris Mravec
Jul 3, 2021·Cancers·Maria-Bernadette Madel, Florent Elefteriou
Aug 5, 2021·Cancer Causes & Control : CCC·Nicole C LoronaChristopher I Li
Aug 24, 2021·Frontiers in Pharmacology·Natansh D ModiAshley M Hopkins
Jun 20, 2021·Anti-cancer Drugs·Miroslav TibenskyBoris Mravec